Johnson & Johnson (JNJ)
149.59
+0.47
(+0.32%)
USD |
NYSE |
Apr 23, 16:00
149.56
-0.03
(-0.02%)
After-Hours: 20:00
Johnson & Johnson Debt to Equity Ratio: 0.4265 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4265 |
| September 30, 2023 | 0.4201 |
| June 30, 2023 | 0.6068 |
| March 31, 2023 | 0.7465 |
| December 31, 2022 | 0.5161 |
| September 30, 2022 | 0.4293 |
| June 30, 2022 | 0.4269 |
| March 31, 2022 | 0.4437 |
| December 31, 2021 | 0.456 |
| September 30, 2021 | 0.4828 |
| June 30, 2021 | 0.4812 |
| March 31, 2021 | 0.5106 |
| December 31, 2020 | 0.5573 |
| September 30, 2020 | 0.5856 |
| June 30, 2020 | 0.4826 |
| March 31, 2020 | 0.45 |
| December 31, 2019 | 0.4657 |
| September 30, 2019 | 0.5019 |
| June 30, 2019 | 0.484 |
| March 31, 2019 | 0.4981 |
| December 31, 2018 | 0.5101 |
| September 30, 2018 | 0.4836 |
| June 30, 2018 | 0.5102 |
| March 31, 2018 | 0.5143 |
| December 31, 2017 | 0.5748 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.4754 |
| June 30, 2017 | 0.4807 |
| March 31, 2017 | 0.4602 |
| December 31, 2016 | 0.3852 |
| September 30, 2016 | 0.3709 |
| June 30, 2016 | 0.3621 |
| March 31, 2016 | 0.3214 |
| December 31, 2015 | 0.2791 |
| September 30, 2015 | 0.276 |
| June 30, 2015 | 0.2714 |
| March 31, 2015 | 0.2797 |
| December 31, 2014 | 0.269 |
| September 30, 2014 | 0.1993 |
| June 30, 2014 | 0.2194 |
| March 31, 2014 | 0.2258 |
| December 31, 2013 | 0.2455 |
| September 30, 2013 | 0.2164 |
| June 30, 2013 | 0.2151 |
| March 31, 2013 | 0.2377 |
| December 31, 2012 | 0.2494 |
| September 30, 2012 | 0.2643 |
| June 30, 2012 | 0.2906 |
| March 31, 2012 | 0.3169 |
| December 31, 2011 | 0.3439 |
| September 30, 2011 | 0.2984 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4201
Minimum
Sep 2023
0.7465
Maximum
Mar 2023
0.4986
Average
0.4826
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| Amgen Inc | 10.37 |
| Gilead Sciences Inc | 1.094 |
| Eli Lilly and Co | 2.342 |
| Merck & Co Inc | 0.9328 |
| Shockwave Medical Inc | 1.094 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 167.56B |
| Total Liabilities (Quarterly) | 98.78B |
| Shareholders Equity (Quarterly) | 68.77B |
| Current Ratio | 1.156 |
| Net Debt Paydown Yield | 2.08% |